[Effect of lactobacillus immunotherapy on genital infections in women (Solco Trichovac/Gynatren)].
In view of the high cure rates of Trichomonas vaginitis after vaccination with the immunotherapeutic drug Solco Trichovac Gynatren, the therapeutic efficacy of this regimen in nonspecific vaginitis was investigated. 94 patients were treated in a multicentre study. Concurrent with a decrease of pathogens, the growth of a normal lactobacilli flora was observed. The degree of vaginal purity according to Schröder and the vaginal pH returned to normal. A cure or at least a marked improvement of symptoms was documented in about 80% of patients. Compared to conventional forms of therapy, this regimen protects against reinfection, thus providing a decisive advantage.
D000328:Adult; D000368:Aged; D001428:Bacterial Vaccines / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007167:Immunotherapy; D007778:Lactobacillus / Q000276:immunology*; D008875:Middle Aged; D014627:Vaginitis / Q000382:microbiology / Q000628:therapy*
D001428:Bacterial Vaccines; C039045:SolcoTrichovac
Wirkung einer Lactobazillus-Immuntherapie auf die Genitalinfektion der Frau (Solco Trichovac/Gynatren).